Prostate cancer cancer‐associated fibroblasts with stable markers post‐androgen deprivation therapy associated with tumor progression and castration resistant prostate cancer

Documenti analoghi

• Insulin resistance during androgen deprivation therapy in men with prostate cancer
  di: Shehzad Basaria, et al.
  Pubblicazione: (2024)
• Survival by first‐line therapy and prognostic group among men with metastatic castration‐resistant prostate cancer
  di: Megan E. V. Caram, et al.
  Pubblicazione: (2024)
• Targeting the cancer cells and cancer‐associated fibroblasts with next‐generation FGFR inhibitors in prostate cancer co‐culture models
  di: Syeda Afshan, et al.
  Pubblicazione: (2024)
• High‐dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCT
  di: Luke J. Peppone, et al.
  Pubblicazione: (2024)
• Clinical impact of real‐time androgen receptor alteration monitoring on metastatic castration‐resistant prostate cancer treatment in real‐world settings
  di: Regina Stitz, et al.
  Pubblicazione: (2025)